BASHE

nanolive.ch 2.0

Switzerland

Nanolive’s label-free live cell imaging and analysis platforms, consumables and services are built on technology that is 100% non-invasive, thus circumventing the use of current end-point assays that damage cells.This allows live cells to be imaged and analyzed for an unlimited amount of time while characterizing their dynamics with the most reliable and quantitative results.Our solutions are accelerating the drug discovery and development workflows of leading biopharma companies, transforming immuno-oncology, pathway discovery, mitochondrial & cell metabolism analysis, and sensitive cell line analytics. We are applying our technology to new research areas such as cell therapy manufacturing, regenerative medicine QA/QC and biotechnology. Budget documents, personal information, company documents, customers' and shareholders' info 16 GB+

2024-11-16 16:00:00

Health Science

Financial data